In this work, we hypothesized that AAT, a highly abundant human plasma neutrophil serine protease inhibitor developed to treat emphysema due to AAT deficiency, protects cardiac grafts after prolonged storage in rat model of HTX. The gene discussed is SERPINA1; the disease is pulmonary emphysema.